(1-(Tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl)boronic acid, 98%, 250mg

Isobutylamine>98.0%(GC)500mL

(R,E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide, 99.0%, 50mg

2-Amino-3-bromo-5-methylbenzoic acid, 98.0%, 500g

3,5-Diiodo-L-thyronine>96.0%(T)1g

Iron foil 99.5% 0.05 x 100 x 100 mm 1 pc

(S)-4-Isopropyl-2-(6-methylpyridin-2-yl)-4,5-dihydrooxazole, 97%, 1g

5-Bromo-6-methoxypyridin-2-amine, 95.0%, 10g

Methyl azepane-3-carboxylate hydrochloride, 95+%, 250mg

2-(Quinolin-2-yl)ethanamine, 95.0%, 250mg

4,5-Dibromothiophene-2-carboxylic acid, 97.0%, 1g

Sinensetin, ROTICHROM® HPLC, 10 mg, glass packaging

4-[(2-AMINOETHYL)SULFONYL]-1-BOC-PIPERAZINE, 95.0%, 2g